Well-organized Patient Assistance Programs (PAPs) facilitate coordinated product and patient journeys, including high-touch care, a smart financial strategy, and prompt medication access. Watch our latest video to learn what UBC is doing throughout every step of our PAPs to support manufacturers and patients alike.
Patient Assistance Programs
We sent one of our experts to the Connected Health Conference in Washington, D.C. On the blog, he recaps three key trends that will impact our industry.
As the specialty market continues to grow, so do the market access challenges associated with these products requiring high-touch services.
Drug innovation has evolved, drastically changing the way certain diseases are treated. In our latest blog post, Nicole Hebbert, Vice President of Patient Access & Engagement, shares her thoughts on how patient support services have changed over the years.
Ahead of the staggering changes brought about by the Affordable Care Act (ACA), many predicted that the need for manufacturer-funded Patient Assistance Programs would decline as patients received coverage from new government sources. Now that we are well into the ACA’s implementation, it’s clear how healthcare reform is impacting PAPs. Our latest blog post examines what changed and what hasn’t.
This year is shaping up to be another exciting one for the UBC team. With nearly 50 conferences already booked for the year, our thought leaders are looking forward to learning, networking, and presenting their work at a host of industry events.
Here is a sampling of our first quarter events. We hope to see you in person very soon!
DIA Pharmacovigilance & Risk Management Strategies: January 25-28, Washington, DC
On behalf of pharmaceutical manufacturers, UBC provides Patient Assistance Programs to support patients in times of need. As a staff pharmacist, I am able to provide assistance to patients using medications for conditions such as narcolepsy, cancer, rheumatoid arthritis, and multiple sclerosis. Narcolepsy in particular requires frequent consultations because the complexity of the medication’s dosage makes accidental overdosing common.
In 2013 alone, UBC’s Patient Assistance Programs served hundreds of specialty and traditional pharmaceutical products, dispensing millions of prescriptions, and helping hundreds of thousands of patients initiate and maintain access to critical therapies. Despite these incredible numbers, our frontline staff of Patient Care Advocates and pharmacists provides personalized care and attention to each patient. This video captures stories from some of our key team members and demonstrates our culture of patient and product advocacy.
At last week’s 15th Annual Patient Assistance and Access Programs conference, I joined more than 400 industry experts to discuss the changing landscape of patient assistance. This is a hot topic that we’ve discussed here on the blog. It will continue to receive attention as the regulations are finalized.
Every generation sees medical advances in treating illnesses and diseases which previously had few treatments available. Before the discovery of penicillin, lives were lost due to pneumonia, typhoid fever, skin infections, and other maladies, now often easily treated. Antiretroviral drugs have greatly improved the health of patients with HIV-AIDS. Protease inhibitors can successfully treat hepatitis C. And cytotoxic antineoplastic drugs, or chemotherapy, are used to treat many forms of cancer once considered fatal.